Analyzing the Possible Impact of Herpes Simplex Virus-1 in Relation to Interleukin-6 Levels in Patients with Oral Squamous Cell Carcinoma
Abstract
Background:
Oral squamous cell carcinoma (OSCC) is the most common malignant tumor of the oral cavity, accounting for more than 90% of all cases. Oral herpes is caused by herpes simplex virus type 1 (HSV-1), a common, benign virus that affects the skin and mucous membranes of individuals with weakened immune systems, causing ulcers. There are several cellular processes that rely on the pleiotropic cytokine interleukin-6 (IL-6), including migration, invasion, differentiation, proliferation, and survival. By modifying tumor angiogenesis and tumor lymphangiogenesis, IL-6 controls tumor growth and its effects on tumor cells.
Methods: The study involved 60 patients divided into two groups: those with and those without oral cancer. The blood was drawn and examined for HSV-1 Immunoglobulin G levels using the Herpe Select-1 ELISA kit. A sandwich ELISA was also employed to study IL-6 levels.
Results: HSV-1 incidence in these oral squamous cell carcinoma grade groups increased significantly. This research found that the OSCC group had somewhat greater IL-6 levels than the control groups.
Conclusion: HSV-1 is not carcinogenic in its own right; however, it is linked to an increased risk of oral squamous cell carcinoma. In addition, the present study discovered that the pro-inflammatory cytokine IL-6 was present in greater quantities in patients' blood than in controls. Interleukin-6 was identified as a potentially hazardous factor in the development of oral cancer and has the potential to function as a valuable biomarker for the assessment of OSCC severity.
Keywords: Oral squamous cell carcinoma; Interleukin 6; Enzyme-Linked Immunosorbent Assay; Herpes simplex virus-1; IgG
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, (2021); 71(3): 209-249.
Koivikko T, Rodrigues PC, Vehviläinen M, Hyvönen P, Sundquist E, et al. Detection of herpes simplex virus in oral tongue squamous cell carcinoma. Frontiers in Pharmacology, (2023); 14(2023): 1182152.
Yan M, Xiao LY, Gosau M, Smeets R, Feng HC, et al. The role of herpes simplex virus infection in the etiology of head and neck cancer–a Mendelian randomization study. Frontiers in Immunology, (2024); 15(2024): 1278327.
Imbesi Bellantoni M, Picciolo G, Pirrotta I, Irrera N, Vaccaro M, et al. Oral cavity squamous cell carcinoma: an update of the pharmacological treatment. Biomedicines, (2023); 11(4): 1112-1117.
Brown SH, States VA, Afghan AK, Satyanarayana G. Herpes simplex virus-infected squamous cell carcinoma: a case report. BMC Infectious Diseases, (2022); 22(1): 1-25.
Jassim MMA, Naji SA, Mahmood MM. BRCA1, BCL2, and the RB Tumor Suppressor have abnormal expressions in lung cancer. Research Journal of Pharmacy and Technology, (2022); 15(9): 4083-4087.
Jain M. Assessment of correlation of herpes simplex virus-1 with oral cancer and precancer-a comparative study. Journal of clinical and diagnostic research, (2016); 10(8): ZC14-7.
Kazem SH, Hussein MH. Immunological Role of IL-17A and Biochemical Factors in Patients with Renal Failure Induced by Systemic Lupus Erythematosus. Iranian Journal of War and Public Health, (2024); 16(1): 61-65.
Abdul-Razzaq LN, Jassim MMA, Mahmood MM. The High Presence of HCMV pp71 Proteins, Correlate with P63 Expression in Pancreatic Cancer Tumor Tissue. Asian Pacific Journal of Cancer Prevention, (2023); 24(4): 1443–1447.
Riedel F, Zaiss I, Herzog D, Götte K, Naim R, et al. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma. Anticancer research, (2005); 25(4): 2761-2765.
Singh PK, Chandra G, Bogra J, Gupta R, Kumar V, et al. Association of interleukin-6 genetic polymorphisms with risk of OSCC in Indian population. Meta Gene, (2005); 4(2005): 142-151.
Dineshkumar T, Ashwini BK, Rameshkumar A, Rajashree P, Ramya R, et al. Salivary and serum interleukin-6 levels in oral premalignant disorders and squamous cell carcinoma: diagnostic value and clinicopathologic correlations. Asian Pacific journal of cancer prevention, (2016); 17(11): 4899–4906.
Harini P, Neralla M, Preethi A, Selvakumar SC. Impact of Interleukin-6 on Oral Squamous Cell Carcinoma Among the South Indian Population. Cureus, (2024); 16(7): 1-6.
Xiao L, Li X, Cao P, Fei W, Zhou H, et al. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway. Journal of Experimental & Clinical Cancer Research, (2022); 41(1): 166.
St John MA, Li Y, Zhou X, Denny P, Ho CM, et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Archives of Otolaryngology–Head & Neck Surgery, (2004); 130(8): 929-935.
Lippitz BE. Cytokine patterns in patients with cancer: a systematic review. The lancet oncology, (2013); 14(6): 218-228.
Maccio A, Madeddu C. The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications - a review. Journal of Molecular Medicine, (2013); 91(2013): 1355-1368.
Ohishi W, Cologne JB, Fujiwara S. Serum interleukin-6 associated with hepatocellular carcinoma risk: a nested case-control study. International Journal of Cancer, (2014); 134(1): 154-163.
Tripsianis G, Papadopoulou E, Anagnostopoulos K. Coexpression of IL-6 and TNF-alpha: prognostic significance on breast cancer outcome. Neoplasma, (1996); 61(2): 205-212.
Lederle W, Depner S, Schnur S. IL-6 promotes malignant growth of skin SCCs by regulating a network of autocrine and paracrine cytokines. International Journal of Cancer, (2011); 128(12): 2803-2814.
Qaysar MS, Mohammed AJM, Mohammed MM. Tracing some salivary immune elements in Iraqi SARS-2 patients. Archives of Razi Institute, (2022); 77(5): 1587-1591.
Kross KW, Heimdal JH, Olsnes C, Olofsson J, Aarstad HJ. Tumor-associated macrophages secrete IL-6 and MCP-1 in head and neck squamous cell carcinoma tissue. Acta oto-laryngologica, (2007); 127(5): 532-539.
Lam-ubol A, Hopkin D, Letuchy EM. Squamous carcinoma cells influence monocyte phenotype and suppress lipopolysaccharide-induced TNF-alpha in monocytes. Inflammation, (2010); 33(4): 207-223.
Lisa Cheng YS, Jordan L, Gorugantula LM. Salivary interleukin-6 and -8 in patients with oral cancer and patients with chronic oral inflammatory diseases. Journal of Periodontology, (2014); 85(7): 956-965.
Chiu YH, Spiegelman D, Dockery DW, Garshick E, Hammond SK, et al. Secondhand smoke exposure and inflammatory markers in nonsmokers in the trucking industry. Environmental health perspectives, (2011); 119(9): 1294-1300.
Jassim MM, Mahmood MM, Ali SH, Kamal MS. Interplay between EBERS and P27 tumor suppressor proteins in molecular transformation of nasopharyngeal and sinonasal carcinomas. Indian Journal of Public Health, (2019); 10(6): 19-26.
Radoi CL, Cristea OM, Vulcanescu DD, Voinescu A, Dragomir TL, et al. Seroprevalence of Herpes Simplex Virus Types 1 and 2 among Pregnant Women in South-Western Romania. Life, (2024); 14(5): 596-533.
Sharma D, Sharma S, Akojwar N, Dondulkar A, Yenorkar N, et al. An insight into current treatment strategies, their limitations, and ongoing developments in vaccine technologies against herpes simplex infections. Vaccines, (2023); 11(2): 206-212.
Jassim MMA, Mahmood MM, Musa SQ. Herpetic Oncogenic Virus Co-Infections Impinge Cell Cycle Regulatory Gene Expressions in Oral Cavity Malignancies. Systematic Reviews in Pharmacy, (2020); 11(3): 760–764.
Eglin RP, Lehner T, Subak-Sharpe JH. Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behcet's syndrome and recurrent oral ulcers. The Lancet, (1982); 320(8312): 1356-1361.
Delavarian Z, Pakfetrat A, Falaki F, Pazouki M, Pazouki N. The role of viruses in oral squamous cell carcinoma in young patients in Khorasan (Northeast of Iran). Journal of Applied Science, (2010); 10(11): 981-985.
DOI: http://dx.doi.org/10.62940/als.v12i2.2126
Refbacks
- There are currently no refbacks.